The RÔMACIL brand, founded in 2014 (United States), from 167 sister brands and 2617 competing brands. RÔMACIL is owned by LONZA GRP, listed on the stock exchange of Zurich Its International Securities Identification Number (ISIN) is CH0013841017. The sector of RÔMACIL is Medical Diagnostics & Research.

Share price and profitability of the share LONZA GRP (RÔMACIL)

Buy LONZA GRP share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested CHF 540.20

Portfolio valuation
LONZA GRP (RÔMACIL) over 5 years* CHF 939.45

Stock market history LONZA GRP (RÔMACIL)